Comparative toxicity and toxicokinetic studies of oxiracetam and (S)-oxiracetam in dogs-Reference-Cited by-同舟云学术

Comparative toxicity and toxicokinetic studies of oxiracetam and (S)-oxiracetam in dogs

Published:2019-01-04 Issue:9 Volume:49 Page:1054-1062
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Liu Tian-tian¹^ORCID,Guo Xin-miao²,Rong Zu-yuan³,Ye Xiang-feng²,Wei Jin-feng¹²,Wang Ai-ping¹²,Jin Hong-tao¹²

Affiliation:

1. New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

2. Beijing Union-Genius Pharmaceutical Technology Co., LTD, Beijing, China;

3. Sichuan Institute for Food and Drug Control, Sichuan, China

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2018.1528027

Reference36 articles.

1. Agency, EM. (1994). Investigation of chiral active substances. http://www.ema.europa.eu/pdfs/human/qwp/3cc29aeu.pdf. [Accessed 21 Jun 2018].

2. Enantiomeric antidepressant drugs should be considered on individual merit

3. Oxiracetam in dementia: a double-blind, placebo-controlled study

4. Guidelines from the International Conference on Harmonisation (ICH)

5. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study;European Journal of Pharmaceutical Sciences;2024-01

2. Co administration of oxiracetam and monosialotetrahexosylganglioside for the treatment of patients with craniocerebral injury, and their effect on serum S100 proteins and neuron specific enolase;Tropical Journal of Pharmaceutical Research;2023-02-18

3. Toxicity and toxicokinetic considerations in product development and drug research;Pharmacokinetics and Toxicokinetic Considerations;2022

4. Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers;European Journal of Drug Metabolism and Pharmacokinetics;2021-09-21